The Claim
In men with hypogonadotropic hypogonadism, discontinuation of gonadotropin therapy reduces seminiferous tubule diameter on ultrasound, and resumption of therapy restores seminiferous tubule diameter, demonstrating that tubule morphology changes in response to hormonal status.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In men with hypogonadotropic hypogonadism, the size of seminiferous tubules measured by ultrasound decreases when gonadotropin therapy is stopped and increases when therapy is restarted, showing that tubule size changes with hormonal levels.
See the scientific wording
In men with hypogonadotropic hypogonadism, the diameter of seminiferous tubules on ultrasound decreases after discontinuation of gonadotropin therapy and recovers upon resumption, indicating that tubule morphology is dynamically responsive to hormonal status.
When hormone signals from the brain reach the testes, they trigger cells inside the sperm-producing tubes to multiply and mature. As more sperm cells develop and fill the tubes, the tubes swell in size. When the hormone signals stop, the sperm cells stop multiplying and the tubes shrink back down.
What the research says
1 studyWhen men with this hormone problem get treatment, their testicle tubes get thicker on ultrasound, and sperm start appearing. When treatment stops, the tubes likely get thinner again — showing that the tubes change size based on hormone levels.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.